Your browser doesn't support javascript.
loading
Patient experiences of continuous glucose monitoring and sensor-augmented insulin pump therapy for diabetes: A systematic review of qualitative studies.
Natale, Patrizia; Chen, Sharon; Chow, Clara K; Cheung, Ngai Wah; Martinez-Martin, David; Caillaud, Corinne; Scholes-Robertson, Nicole; Kelly, Ayano; Craig, Jonathan C; Strippoli, Giovanni; Jaure, Allison.
Afiliação
  • Natale P; Sydney School of Public Health, The University of Sydney, Sydney, Australia.
  • Chen S; Department of Precision and Regenerative Medicine and Ionian Area (DIMEPRE-J), University of Bari Aldo Moro, Bari, Italy.
  • Chow CK; Nephrology, Dialysis and Transplantation Unit, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.
  • Cheung NW; Sydney School of Public Health, The University of Sydney, Sydney, Australia.
  • Martinez-Martin D; Centre for Kidney Research, The Children's Hospital at Westmead, Sydney, Australia.
  • Caillaud C; Westmead Applied Research Centre, Westmead Hospital, Sydney, Australia.
  • Scholes-Robertson N; Sydney Medical School, The University of Sydney, Sydney, Australia.
  • Kelly A; Westmead Applied Research Centre, Westmead Hospital, Sydney, Australia.
  • Craig JC; Sydney Medical School, The University of Sydney, Sydney, Australia.
  • Strippoli G; Westmead Clinical School, Westmead Hospital, Sydney, Australia.
  • Jaure A; The University of Sydney Nano Institute (Sydney Nano), The University of Sydney, Sydney, Australia.
J Diabetes ; 15(12): 1048-1069, 2023 Dec.
Article em En | MEDLINE | ID: mdl-37551735
ABSTRACT

AIMS:

Blood glucose control is central to the management of diabetes, and continuous glucose monitoring (CGM) improves glycemic control. We aimed to describe the perspectives of people with diabetes using CGM. MATERIALS AND

METHODS:

We performed a systematic review of qualitative studies.

RESULTS:

Fifty-four studies involving 1845 participants were included. Six themes were identified gaining control and convenience (reducing pain and time, safeguarding against complications, achieving stricter glucose levels, and sharing responsibility with family); motivating self-management (fostering ownership, and increasing awareness of glycemic control); providing reassurance and freedom (attaining peace of mind, and restoring social participation); developing confidence (encouraged by the endorsement of others, gaining operational skills, customizing settings for ease of use, and trust in the device); burdened with device complexities (bewildered by unfamiliar technology, reluctant to rely on algorithms, overwhelmed by data, frustrated with malfunctioning and inaccuracy, distressed by alerts, and bulkiness of machines interfering with lifestyle); and excluded by barriers to access (constrained by cost, lack of suppliers).

CONCLUSIONS:

CGM can improve self-management and confidence in patients managing diabetes. However, the technical issues, uncertainty in readings, and cost may limit the uptake. Education and training from the health professionals may help to reduce the practical and psychological burden for better patient outcomes.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 1 / Insulinas / Hiperinsulinismo Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 1 / Insulinas / Hiperinsulinismo Idioma: En Ano de publicação: 2023 Tipo de documento: Article